MONTVALE, N.J., June 6 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that David A. Lowe, Ph.D., Chief Scientific Officer, will provide a company update at the 6th Annual Needham & Company Biotechnology & Medical Technology Conference on Wednesday, June 13, 2007, at 4:00 p.m. ET. The conference is being held at The New York Palace Hotel in New York City.
Interested parties may access the live webcast of the presentation by visiting the “Investors” section of Memory Pharmaceuticals’ website at http://www.memorypharma.com. Archived versions of the webcast will be available at the same location for one week following the presentation.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.
CONTACT: Jzaneen Lalani, General Counsel of Memory Pharmaceuticals Corp.,+1-201-802-7249; or Laura Perry of Stern Investor Relations, Inc. forMemory Pharmaceuticals Corp., +1-212-362-1200
Web site: http://www.memorypharma.com//
